Immunosuppressive and anticancer effect of a mammalian ribonuclease that targets high-affinity interleukin-2-receptors

European Journal of Surgery

Volumn 168, Issue 1, 2002, Pages 49-54

  Yamamura, Tadashi ^a   Ueda, Masakazu ^a   Psarras, Kyriakos ^a   Suwa, Tatsushi ^b   Watanaabe, Yasuo ^c   Kameyama, Noriaki ^d   Tanabe, Minoru ^e   Imamura, Hiroji ^e   Kitajima, Masaki ^f  

^a DIVISION OF REPRODUCTIVE BIOLOGY   (United States)

^b UNIVERSITY OF LONDON   (United Kingdom)

^c RESEARCH AND DEVELOPMENT   (Australia)

^d College of Chemistry and Molecular Engineering ^*  (China)

^e UNIVERSITY OF SHEFFIELD   (United Kingdom)

^f KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cd25; Conjugate protein; Immunosuppressive agent; Immunotoxin; Interleukin 2 receptor; Monoclonal antibody; Ribonuclease

Indexed keywords

INTERLEUKIN 2 RECEPTOR; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 7G7B6; RIBONUCLEASE A; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BINDING AFFINITY; CELL CULTURE; CELL ISOLATION; CELL LINE; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG CONJUGATION; DRUG RECEPTOR BINDING; DRUG TARGETING; GENE OVEREXPRESSION; GRAFT REJECTION; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; IC 50; IMMUNOSUPPRESSIVE TREATMENT; LEUKEMIA CELL LINE; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE;

ANIMALS; ANTINEOPLASTIC AGENTS; CATTLE; CELL DIVISION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LYMPHOCYTE CULTURE TEST, MIXED; LYMPHOCYTES; MICE; RECEPTORS, INTERLEUKIN-2; RIBONUCLEASE, PANCREATIC;

EID: 0036219626     PISSN: 11024151     EISSN: None     Source Type: Journal    
DOI: 10.1080/110241502317307571     Document Type: Article

References (16)

1. Immunotoxins against cancer
2. Attenuation of graft-versus-host disease and graft rejection by ex vivo immunotoxin elimination of alloreactive T cells in an H-2 haplotype disparate mouse combination
3. A recombinant immunotoxin consisting of two antibody variable domains fused to pseudomonas exotoxin
4. Use of Yttrium-90-labeled anti-Tac antibody in primate xenograft transplantation
5. The effect of a new immunosuppressive drug, brequinar sodium, on heart, liver, and kidney allograft rejection in the rat
6. Recombinant human pancreatic ribonuclease produced in E. coli: Importance of the amino-terminal sequence
7. Treatment of corneal allograft rejection with the cytotoxin 11-2-PE40
8. Epidermal growth factor receptor-dependent cytotoxicity for human squamous carcinoma cell lines of a conjugate composed of human EGF and RNaseA
9. Anti-Tac(Fab)-PE40, a recombinant double-chain immunotoxin which kills interleukin-2-receptor-bearing cells and induces complete remission in an in vivo tumor model
10. Cytokine receptors and signal transduction
11. Cytotoxic ribonuclease chimeras. Targeted tumoricidal activity in vitro and in vivo
12. Humanization of immunotoxin
13. Cytotoxic potential of ribonuclease and ribonuclease hybrid proteins
14. The interleukin-2 receptor gamma chain: Its role in the multiple cytokine receptor complexes and T-cell development in XSCID
15. Functional study of residual T lymphocytes after specific elimination of alloreactive T cells by a specific ami-interleukin-2 receptor BK chain immunotoxin
16. Comparative in vitro studies on the immunosupressive activities of mycophenolic acid, bredinin, FK506, cyclosporine, and rapamycin